Make sure to scroll down for recent health news & videos!
Morris Ave Rx & Health Center Logo

Manténgase sano!

Resultados de su búsqueda "Diabetes: Drugs".

Resultados de noticias de salud - 33

For people struggling with both diabetes and a common type of heart failure, the weight-loss drug Wegovy may do more for their health than help them shed pounds, new research suggests.

In the study, published Saturday in the New England Journal of Medicine, researchers reported that the drug helped people with typ...

The U.S. Food and Drug Administration on Tuesday approved the country's first continuous glucose monitor for type 2 diabetes.

The new Dexcom Stelo Glucose Biosensor System, which will be available by summer, is intended for people 18 and older who have type 2 diabetes but do not take insulin, according to the agency.

Also known as CGMs, these monitors consist of tiny sensors that pr...

The U.S. Food and Drug Administration is investigating reports of additional dangers linked to several wildly popular weight-loss drugs.

In a quarterly report...

Managing diabetes will be a less expensive proposition for more Americans in 2024.

Sanofi has officially joined Novo Nordisk and Eli Lilly in lowering the cost of insulin to $35 a month for many patients. The three drugmakers are also drastically lowering the list prices for their insulin pr...

New research suggests some newer diabetes treatments may not be as beneficial for Black patients, after earlier drug trials included small numbers of non-white people.

Whether the medications -- called sodium-glucose co-transporter 2 inhibitors (SGLT2-Is) and glucogen-like peptide 1 receptor agonists (GLP1-Ras) -- actually have less benefit for Black patients or whether the small sample s...

Another diabetes drug maker is taking legal action against businesses in several states, alleging that they're "fraudulently claiming"that their compounded products are the same as its medication.

This time, it's Eli Lilly suing certain medical spas, wellness centers and compounding pharmacies over its medication Mounjaro.

Mounjaro contains the active ingredient tirzepatide and is ...

As demand for the wildly popular weight-loss drug Wegovy continues to climb, drug maker Novo Nordisk said Thursday that it will continue restrictions on starter doses of the medication into 2024.

The new plan extends by months existing restrictions and means patients who are not already taking the medication will have to wait to start.

"We are going to continue to supply the market,...

The diabetes drug metformin might also benefit older patients after an injury or illness, a small study suggests.

Researchers found that metformin -- a drug that has been around for more than a half-century to regulate blood sugar -- may have a different ability: It can target senescent cells that affect muscle function. These "zombie-like" cells release chemicals linked with inflammation...

People with type 2 diabetes could soon have access to convenient once-a-week insulin shots that could replace the daily injections now required.

A once-weekly insulin formulation called icodec performed just as well as daily doses of the insulin degludec, phase 3 clinical trial results show.

Icodec now awaits approval by the U.S. Food and Drug Administration based on these results, ...

You have been diagnosed with type 2 diabetes. What are your medication options?

That depends on what type of diabetes you have and what risk factors you carry.

In type 2 diabetes, the body becomes resistant to the insulin and the pancreas has to make more. Insulin resistance can be caused by obesity, lack of exercise, medication, stress or hereditary factors. Initially, the pancreas...

The trendy weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia for an operation, according to a new warning from the American Society of Anesthesiologists.

Semaglutide (Ozempic, Wegovy) and other drugs of their class known as GLP-1 receptor agonists cause digestion to slow down, which decreases hunger and reduces how much people eat.

That food left in the...

After drugmaker Novo Nordisk tweaked its diabetes drug Ozempic into Wegovy -- a formulation expressly designed to help users shed pounds -- sales of both drugs skyrocketed.

Other pharmaceutical giants took notice, and over the past weekend the results of multiple clinical trials from would-be competitors were unveiled at this year's annual meeting of the American Diabetes Association (ADA...

The maker of three popular drugs that treat weight loss and diabetes said Tuesday that it has begun legal proceedings against businesses that are selling compounded versions of its products that are not approved by the U.S. Food and Drug Administration.

In a sta...

A safe, generic diabetes pill can help people avoid long COVID, a new clinical trial shows.

Metformin cut the risk of long COVID by about 40% for patients who received a two-week course of the drug while battling their infection, the researchers reported.

The results were even more dramatic if COVID-19 patients began taking metformin soon after infection. Starting on the drug w...

There are many medications for type 2 diabetes, but one class may stand out for protecting the heart, a new study suggests.

The study, of thousands of U.S. veterans with diabetes, found that those who added drugs called GLP-1 receptor agonists to their usual regimen were somewhat less likely to suffer a first-time heart attack or stroke in coming years.

That was in comparison to vet...

More Americans will soon be paying less for their insulin.

Eli Lilly, one of the three insulin manufacturers, plans to cut its list prices of the drug by 70% and cap out-of-pocket costs at $35 a month.

"While the current health care system provides access to insulin for most people with diabetes, it still does not provide affordable insulin for everyone, and that needs to change," E...

Most Americans with type 2 diabetes are candidates for newer, pricey medications, but few are getting them, a new government study shows.

Researchers found that of U.S. adults with the blood sugar disease, over 80% could stand to benefit from the medications, based on recommendations from the American Diabetes Association (ADA). But only 10% of those people were actually taking the drugs ...

While people with type 1 diabetes can see some benefit from newer medications prescribed off-label, there is also risk, and these patients should be monitored closely, according to a new study.

Type 1 diabetes is universally treated with insulin injections, but only about one-fifth of patients achieve blood sugar control with it,

  • Cara Murez HealthDay Reporter
  • |
  • February 20, 2023
  • |
  • Página completa
  • Elon Musk swears by the weight-loss drug Wegovy, and Kim Kardashian is rumored to have used it to shed 16 pounds in three weeks to squeeze into a vintage gown once worn by Marylin Monroe.

    But the intense public demand for Wegovy has triggered a shortage of the diabetes version of the injectable medication, known as Ozempic. That's leaving patients with the blood sugar disease in a real bi...

    Insulin pumps can help folks with type 1 diabetes get better control of their disease and minimize how often they inject insulin, and use of the devices has taken off in the past 20 years.

    That's the good news from a new study.

    The not-so-great news is that a large gap in wh...

    Owners whose cats have diabetes now have a new option to care for the condition in their otherwise healthy pets.

    The U.S. Food and Drug Administration on Thursday approved the first pill to improve control of diabetes in some cats.

    The drug, call...

    A century-old diabetes drug seems to help keep high-risk COVID-19 patients from falling deathly ill, a new study reports.

    Metformin reduced the risk of death from COVID-19 by 44% in a group of diabetics who were taking the drug when they became infected with the coronavirus, according t...

    California's plan to manufacture its own insulin could be a huge money-saver for state residents with diabetes -- and possibly be a model for other states, according to experts.

    Earlier this year, California announced an initiative to bring its own insulin products to market, in response to the steep costs of the lifesaving drug in the United States.

    And if it's successful, it will ...

    An older class of type 2 diabetes drugs known as thiazolidinediones, or TZDs, may protect you from dementia down the road, according to new research.

    Thiazolidinediones, also known as glitazones, cut dementia risk by 22% among folks at high risk who also had mild or moderate type 2 diabetes when they took these me...

    More than 1 million Americans with diabetes have to ration lifesaving insulin because they can't afford it, a new study shows.

    Many people delayed picking up their insulin prescription, while others took lower doses than they needed, researchers found.

    Exp...

    Two common diabetes medications seem to outperform two others when it comes to controlling blood sugar levels, a large U.S. trial has found.

    The trial of more than 5,000 people with type 2 diabetes found that two injection medications -- a long-acting insulin and

  • Amy Norton HealthDay Reporter
  • |
  • September 22, 2022
  • |
  • Página completa
  • People with type 1 diabetes who need to inject insulin a few times a day could eventually be switching to an easier-to-take tablet that dissolves inside the cheek.

    Canadian researchers working with rodents report they have created an insulin that could be taken in pill form without most of bein...

    The popular diabetes drug Januvia may contain traces of a probable carcinogen, but patients should keep using the medication because it could be dangerous to stop taking it, the U.S. Food and Drug Administration announced this week.

    Despite the discovery that Nitroso-STG-19 (NTTP) had been found in some samples of the drug, known generically as

  • By Cara Murez HealthDay Reporter
  • |
  • August 12, 2022
  • |
  • Página completa
  • Babies born to fathers who were taking the common diabetes drug metformin may have a slightly increased risk of certain birth defects, a large new study suggests.

    Among over 1 million babies born in Denmark, just over 3% had a birth defect of some kind. But that rate was roughly 5% among babies whose fathers ...

    Katherine Stewart, 16, must take six to 10 insulin shots a day to properly manage her type 1 diabetes.

    Her Highland, Utah, family pays $500 a month out of pocket for her insulin. Before they meet their insurance's deductible, they shell out the cash price of nearly $2,000 a month.

    Now Stewart is preparing to leave the nest, and she doesn't know how she'll be able to afford it.

    A drug widely used to treat osteoporosis might reduce the risk of type 2 diabetes, a new study suggests.

    Taking the drug alendronate (Fosamax) for at least eight years could potentially reduce a person's risk of type 2 diabetes by more than half, compared to people never prescribed the drug, according to findings presented Sunday at the annual meeting of the European Association for the S...

    Metformin, a commonly prescribed diabetes drug, may help stave off preterm birth among women who develop pregnancy-related high blood pressure.

    Preeclampsia is marked by a sudden spike in blood pressure, protein in urine, or other problems during pregnancy. Preterm preeclampsia occurs between 26 and 32 weeks of pregnancy and often leads to early delivery, putting babies at risk. Preemies ...

    Older adults who take certain diabetes drugs may see a slower decline in their memory and thinking skills, a new study suggests.

    Researchers in South Korea found that among older people who'd been having memory issues, those using diabetes drugs called DDP-4 inhibitors typically showed a slower progression in those symptoms over the next few years. That was compared with both diabetes-fre...